Posted by Peterng123 > 2021-04-21 09:55 | Report Abuse

We expect UEME’s earnings to grow robustly at 67% CAGR in 2021-23F as it stands to be the prime beneficiary of the economic reopening and healthcare industry growth, being among the major laggards in the market. This will support its dividend payout ratio of 70%, providing yields of 5-7% for 2021-23F, which is consistent with its dividend policy. It is also expected to be eligible for FTSE4Good Bursa Malaysia (F4GBM) Index inclusion this year. Initiate coverage with BUY. Target price: RM2.30. Find out more by clicking the link: https://research.uobkayhian.com/content_download.jsp?id=62055&h=5f6cf32c38c1ca47bb47534611d55824